
Category: 2024


Granules India achieves SBTi approval for ambitious net-zero goals

Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder

Granules India Launches ‘Breast Health Express’ Mobile Unit For Cancer Screening

Granules India gets USFDA nod for generic Glycopyrrolate oral solution

USFDA gives nod to Granules India’s generic formulation to treat depression

Empowering Women, Driving Change: Priyanka Chigurupati On Leadership And Inclusivity In The Health Industry

Granules India announces ANDA approval for Colchicine Capsules, drug has annual US sales of $55 million

Granules API, formulations facility in Vizag completes U.S. FDA inspection
